HIGHLIGHTS
- who: Zhimou Cai from the All study designs and test procedures were performed in accordance with the Helsinki Declaration IIThe study was approved by the ethics board of IEC for Clinical Research and Animal Trials of the First Affiliated Hospital of Sun Yat-sen University (approval no. [2020]220-1). All patients in this study signed informed consent and agreed to follow up after treatment. have published the article: Mast cell marker gene signature in head and neck squamous cell carcinoma, in the Journal: (JOURNAL)
- what: For this analysis, IPSs of patients with HNSCC were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.